🇧🇷 Tafinlar in Brazil

Tafinlar (dabrafenib) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Tafinlar in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Brazil

Frequently asked questions

Is Tafinlar approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Tafinlar in Brazil?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.